Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR2 | O95136 | 5/20 | 0.57 |
| ▸ | S1PR1 | P21453 | 5/20 | 0.57 |
| ▸ | S1PR3 | Q99500 | 5/20 | 0.57 |
| ▸ | S1PR4 | O95977 | 4/20 | 0.57 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 4/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.52 |
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.52 |
| ▸ | TP53 | P04637 | 2/20 | 0.52 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.52 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.52 |
| ▸ | GMNN | O75496 | 1/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.52 |
| ▸ | THPO | P40225 | 1/20 | 0.52 |
| ▸ | MTOR | P42345 | 1/20 | 0.52 |
| ▸ | BLM | P54132 | 1/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8686906 | 1.00 | S1PR2 (0.57) | S1PR2S1PR1S1PR3S1PR4OPRM1 | |
| SCHEMBL10822877 | 1.00 | S1PR2 (0.57) | S1PR2S1PR1S1PR3S1PR4OPRM1 | |
| SCHEMBL3962483 | 1.00 | S1PR2 (0.57) | S1PR2S1PR1S1PR3S1PR4OPRM1 | |
| SCHEMBL3395218 | 1.00 | S1PR2 (0.57) | S1PR2S1PR1S1PR3S1PR4OPRM1 | |
| SCHEMBL6321434 | 1.00 | S1PR2 (0.57) | S1PR2S1PR1S1PR3S1PR4OPRM1 | |
| SCHEMBL8686837 | 1.00 | S1PR2 (0.57) | S1PR2S1PR1S1PR3S1PR4OPRM1 | |
| SCHEMBL8054198 | 1.00 | S1PR2 (0.57) | S1PR2S1PR1S1PR3S1PR4OPRM1 | |
| SCHEMBL9184259 | 1.00 | S1PR2 (0.57) | S1PR2S1PR1S1PR3S1PR4OPRM1 | |
| SCHEMBL8688414 | 1.00 | S1PR2 (0.57) | S1PR2S1PR1S1PR3S1PR4OPRM1 | |
| SCHEMBL818216 | 1.00 | S1PR2 (0.57) | S1PR2S1PR1S1PR3S1PR4OPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 168 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7105628-B2 | Compositions for golf equipment | ACUSHNET COMPANY (US) | 2006-09-12 | — | — | US | claimed |
| US-20040220378-A1 | Compositions for golf equipment | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR ADMINISTRATIVE AGENT | 2004-11-04 | — | — | US | claimed |
| US-4529528-A | Reacting an alkoxylated amine and a phosphite | MOBIL OIL CORPORATION (US) | 1985-07-16 | — | — | US | claimed |
| US-20230011118-A1 | INHIBITORS OF APOL1 AND METHODS OF USING SAME | VERTEX PHARMACEUTICALS INCORPORATED | 2023-01-12 | — | — | US | disclosed |
| EP-3423554-B1 | LUBRICATING OIL COMPOSITION HAVING IMPROVED AIR RELEASE | LUBRIZOL CORP (US) | 2022-08-10 | — | — | EP | disclosed |
| US-20200318027-A1 | Lubricating Oil Composition Having Improved Air Release | LUBRIZOL CORP (US) | 2020-10-08 | — | — | US | disclosed |
| EP-3423554-A1 | LUBRICATING OIL COMPOSITION HAVING IMPROVED AIR RELEASE | The Lubrizol Corporation (US) | 2019-01-09 | — | — | EP | disclosed |
| US-9433827-B2 | Golf equipment formed from castable formulation with unconventionally low hardness and increased shear resistance | ACUSHNET COMPANY (US) | 2016-09-06 | — | — | US | disclosed |
| US-20150072807-A1 | GOLF EQUIPMENT FORMED FROM CASTABLE FORMULATION WITH UNCONVENTIONALLY LOW HARDNESS AND INCREASED SHEAR RESISTANCE | ACUSHNET COMPANY (US) | 2015-03-12 | — | — | US | disclosed |
| US-8907040-B2 | Golf equipment formed from castable formulation with unconventionally low hardness and increased shear resistance | ACUSHNET COMPANY (US) | 2014-12-09 | — | — | US | disclosed |
| US-20130137537-A1 | GOLF EQUIPMENT FORMED FROM CASTABLE FORMULATION WITH UNCONVENTIONALLY LOW HARDNESS AND INCREASED SHEAR RESISTANCE | ACUSHNET COMPANY (US) | 2013-05-30 | — | — | US | disclosed |
| US-4992184-A | Reaction product of arylsulfonic acid and (diol or amine) phosphite | MOBIL OIL CORPORATION (US) | 1991-02-12 | — | — | US | disclosed |
| US-4965002-A | Reaction product of alkoxylated amine and organic phosphize | ELCO CORPORATION (US) | 1990-10-23 | — | — | US | disclosed |
| EP-0325977-A1 | Phosphite amine lubricant additives | THE ELCO CORPORATION (US) | 1989-08-02 | — | — | EP | disclosed |
| EP-0309486-A1 | PHOSPHOROUS- AND SULFUR-CONTAINING LUBRICANT AND FUNCTIONAL FLUID COMPOSITIONS | The Lubrizol Corporation (US) | 1989-04-05 | — | — | EP | disclosed |
| US-4755311-A | Borated amine salt of dihydrocarbyl monothiophosphoric acid | THE LUBRIZOL CORPORATION (US) | 1988-07-05 | — | — | US | disclosed |
| WO-1987007638-A2 | PHOSPHOROUS- AND SULFUR-CONTAINING LUBRICANT AND FUNCTIONAL FLUID COMPOSITIONS | THE LUBRIZOL CORPORATION (US) | 1987-12-17 | — | — | WO | disclosed |
| US-4557845-A | FRICTION REDUCERS AND FUEL CONSUMPTION REDUCERS | MOBIL OIL CORPORATION (US) | 1985-12-10 | — | — | US | disclosed |
| US-4529528-A | Reacting an alkoxylated amine and a phosphite | MOBIL OIL CORPORATION (US) | 1985-07-16 | — | — | US | disclosed |
| US-3972890-A | ACID CATALYST | BAYER AKTIENGESELLSCHAFT (DT) | 1976-08-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230011118-A1 | INHIBITORS OF APOL1 AND METHODS OF USING SAME | APOL1, APOB, SAAL1 | S1PR2 625/4885S1PR1 553/4885S1PR3 933/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.